Is Kymera Therapeutics Inc (KYMR) Stock Worth a Buy Tuesday?

Kymera Therapeutics Inc (KYMR) stock is down -43.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives KYMR stock a score of 35 out of a possible 100.

That rank is influenced by a short-term technical score of 2. KYMR's rank also includes a long-term technical score of 13.

KYMR has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on KYMR!

See Full KYMR Report

What's Happening with KYMR Stock Today

Kymera Therapeutics Inc (KYMR) stock is higher by 13.96% while the S&P 500 is higher by 0.21% as of 10:21 AM on Tuesday, Nov 7. KYMR is higher by $2.01 from the previous closing price of $14.40 on volume of 178,602 shares. Over the past year the S&P 500 has gained 14.93% while KYMR is down -43.49%. KYMR lost -$2.88 per share in the over the last 12 months. Click Here to get the full Stock Report for Kymera Therapeutics Inc stock.